PGH
TNDM icon

Partners Group Holding’s Tandem Diabetes Care TNDM Stock Holding History

Partners Group Holding’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,647
Closed -$222K – 95
2022
Q3 		$222K Hold
4,647
– – 0.02% 94
2022
Q2 		$275K Sell
4,647
-2,684
-37% -$220K 0.02% 104
2022
Q1 		$853K Buy
7,331
+2,160
+42% +$252K 0.04% 46
2021
Q4 		$778K Hold
5,171
– – 0.04% 42
2021
Q3 		$617K Buy
+5,171
New +$570K 0.04% 61

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Partners Group Holding's TNDM Position: Q4 2022 in Review

Partners Group Holding sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 4,647 shares — an estimated $222K sold.

Partners Group Holding first reported a position in TNDM in Q3 2021 and held it in 5 quarters. The position peaked at $853K in Q1 2022. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • Partners Group Holding reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • Partners Group Holding sold 4,647 Tandem Diabetes Care shares in Q4 2022, an estimated $222K.
  • Partners Group Holding first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 5 quarters.
  • Partners Group Holding's Tandem Diabetes Care position peaked at $853K in Q1 2022.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Partners Group Holding's 13F filing for Q4 2022, filed 14 Feb 2023.